SEOM Clinical Guideline for the diagnosis and treatment of esophageal cancer (2016)
-
M. Martin-Richard [1] ; R. Díaz Beveridge [9] ; V. Arrazubi [2] ; M. Alsina [10] ; M. Galan Guzmán [3] ; A. B. Custodio [4] ; C. Gómez [5] ; F. L. Muñoz [6] ; R. Pazo [7] ; F. Rivera [8]
-
[1] Hospital de la Santa Creu i Sant Pau
Hospital de la Santa Creu i Sant Pau
Barcelona, España
-
[2] Hospital Universitario de Basurto
Hospital Universitario de Basurto
Bilbao, España
-
[3] Hospital Duran i Reynals
Hospital Duran i Reynals
Barcelona, España
-
[4] Hospital Universitario La Paz
Hospital Universitario La Paz
Madrid, España
-
[5] Hospital Universitario 12 de Octubre
Hospital Universitario 12 de Octubre
Madrid, España
-
[6] Hospital Ramón y Cajal
Hospital Ramón y Cajal
Madrid, España
-
[7] Hospital Miguel Servet
Hospital Miguel Servet
Zaragoza, España
-
[8] Hospital Universitario Marqués de Valdecilla
Hospital Universitario Marqués de Valdecilla
Santander, España
-
[9] Hospital Universitari i Politècnic la Fe, España
-
[10] Hospital Vall d´Hebron, España
-
- Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 18, Nº. 12 (December 2016), 2016, págs. 1179-1186
- Idioma: inglés
- Texto completo no disponible (Saber más ...)
-
Resumen
Esophageal cancer (EC) is an aggressive tumor that represents the 6th most common cause of cancer death worldwide. The estimated incidence in Spain is 2090 cases/year. Two main pathological subtypes exist, squamous cell carcinoma and adenocarcinoma. The main differences between them are localization and underlying factors which are the principal cause of the recent incidence changes observed in west countries. Staging techniques and treatment options which combine surgery, chemotherapy and radiotherapy, reflected the high complexity of the EC management. An undeniably multidisciplinary approach is, therefore, required. In this guide, we review the status of current diagnosis and treatment, define evidence and propose recommendations.
